AJP - Renal Physiology, Vol 267, Issue 3 331-F346, Copyright © 1994 by American Physiological Society

ARTICLES

Role of arginine in health and in renal disease

A. A. Reyes, I. E. Karl and S. Klahr

In addition to participating in protein synthesis in cells and tissues, L-arginine is essential for the synthesis of urea, creatine, creatinine, nitric oxide, and agmatine and influences hormonal release and the synthesis of pyrimidine bases. This places L-arginine, its precursors and its metabolites at the center of the interaction of different metabolic pathways and interorgan communication. Thus L-arginine participates in changing the internal environment in different but simultaneous ways, ranging from disposal of protein metabolic waste, muscle metabolism, vascular regulation, immune system function, and neurotransmission, to RNA synthesis and hormone-mediated regulation of the internal milieu. In normal rats, inhibition of the nitric oxide pathway results in systemic hypertension and decreased glomerular filtration rate and effective renal plasma flow. If the inhibition of this pathway is sustained, then glomerulosclerosis and death from uremia follow. Dietary intervention with L-arginine has resulted in amelioration of a number of experimental kidney diseases, such as those caused by subtotal nephrectomy, diabetic, nephropathy, cyclosporin A administration, salt-sensitive hypertension, ureteral obstruction, puromycin amino-nucleoside nephrosis, kidney hypertrophy due to high-protein feeding, and glomerular thrombosis due to administration of lipopolysaccharide. The present review addresses the current evidence for the beneficial effects of dietary intervention with L-arginine in a number of experimental renal diseases and describes the basis for the concept of L-arginine deficiency (absolute or relative) in certain settings in which supplementation of the diet with this amino acid may be beneficial.

This article has been cited by other articles:

				H.-S. Huang, M.-C. Ma, and J. Chen Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition Am J Physiol Renal Physiol, August 1, 2008; 295(2): F388 - F396. [Abstract] [Full Text] [PDF]

				J. Satriano, R. Cunard, O. W. Peterson, T. Dousa, F. B. Gabbai, and R. C. Blantz Effects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generation Am J Physiol Renal Physiol, April 1, 2008; 294(4): F795 - F800. [Abstract] [Full Text] [PDF]

				C. Baylis Nitric oxide deficiency in chronic kidney disease Am J Physiol Renal Physiol, January 1, 2008; 294(1): F1 - F9. [Abstract] [Full Text] [PDF]

				K. A. Munger, R. C. Blantz, and M. J. Lortie Acute renal response to LPS: impaired arginine production and inducible nitric oxide synthase activity Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R684 - R691. [Abstract] [Full Text] [PDF]

				M. J. Lortie, J. Satriano, F. B. Gabbai, S. Thareau, S. Khang, A. Deng, D. P. Pizzo, S. C. Thomson, R. C. Blantz, and K. A. Munger Production of arginine by the kidney is impaired in a model of sepsis: early events following LPS Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1434 - R1440. [Abstract] [Full Text] [PDF]

				A Cremades, C Ruzafa, F Monserrat, A J Lopez-Contreras, and R Penafiel Influence of dietary arginine on the anabolic effects of androgens J. Endocrinol., November 1, 2004; 183(2): 343 - 351. [Abstract] [Full Text] [PDF]

				V. B. Braulio, G. A. M. Ten Have, Y. L. J. Vissers, and N. E. P. Deutz Time course of nitric oxide production after endotoxin challenge in mice Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E912 - E918. [Abstract] [Full Text] [PDF]

				M. Sabbatini, A. Pisani, F. Uccello, G. Fuiano, R. Alfieri, A. Cesaro, B. Cianciaruso, and V. E. Andreucci Arginase inhibition slows the progression of renal failure in rats with renal ablation Am J Physiol Renal Physiol, April 1, 2003; 284(4): F680 - F687. [Abstract] [Full Text] [PDF]

				A. Schaefer, C. Simon, A. Viola, F. Piquard, B. Geny, and G. Brandenberger L-Arginine: An Ultradian-Regulated Substrate Coupled With Insulin Oscillations in Healthy Volunteers Diabetes Care, January 1, 2003; 26(1): 168 - 171. [Abstract] [Full Text] [PDF]

				D. Teixeira, M. L. Santaolaria, V. Meneu, and E. Alonso Dietary Arginine Slightly and Variably Affects Tissue Polyamine Levels in Male Swiss Albino Mice J. Nutr., December 1, 2002; 132(12): 3715 - 3720. [Abstract] [Full Text] [PDF]

				M. J Bruins, P. B Soeters, W. H Lamers, and N. E. Deutz L-Arginine supplementation in pigs decreases liver protein turnover and increases hindquarter protein turnover both during and after endotoxemia Am. J. Clinical Nutrition, June 1, 2002; 75(6): 1031 - 1044. [Abstract] [Full Text] [PDF]

				S. COMBET, M.-L. FERRIER, M. V. LANDSCHOOT, M. STOENOIU, P. MOULIN, T. MIYATA, N. LAMEIRE, and O. DEVUYST Chronic Uremia Induces Permeability Changes, Increased Nitric Oxide Synthase Expression, and Structural Modifications in the Peritoneum J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2146 - 2157. [Abstract] [Full Text] [PDF]

				S. Xiao, L. Wagner, J. Mahaney, and C. Baylis Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells Am J Physiol Renal Physiol, June 1, 2001; 280(6): F989 - F995. [Abstract] [Full Text] [PDF]

				S. Xiao, A. Erdely, L. Wagner, and C. Baylis Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function Am J Physiol Renal Physiol, June 1, 2001; 280(6): F996 - F1000. [Abstract] [Full Text] [PDF]

				I. H. C. VOS, T. J. RABELINK, B. DORLAND, R. LOOS, B. V. MIDDELAAR, H.-J. GRÖNE, and J. A. JOLES L-Arginine Supplementation Improves Function and Reduces Inflammation in Renal Allografts J. Am. Soc. Nephrol., February 1, 2001; 12(2): 361 - 367. [Abstract] [Full Text]

				T. Arai, K. Morimoto, M. Oka, T. Hikita, K. Arai, K. Umezawa, M. Nagase, and T. Yamamoto Aminoguanidine induces haematuria of non-glomerular origin in spontaneously hypertensive rats Nephrol. Dial. Transplant., June 1, 2000; 15(6): 811 - 817. [Abstract] [Full Text] [PDF]

				M. J. Lortie, S. Ishizuka, D. Schwartz, and R. C. Blantz Bioactive products of arginine in sepsis: tissue and plasma composition after LPS and iNOS blockade Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1191 - C1199. [Abstract] [Full Text] [PDF]

				J. Gloy, S. Reitinger, K.-G. Fischer, R. Schreiber, A. Boucherot, K. Kunzelmann, P. Mundel, and H. Pavenstadt Amino acid transport in podocytes Am J Physiol Renal Physiol, June 1, 2000; 278(6): F999 - F1005. [Abstract] [Full Text] [PDF]

				M. Ketteler, R. Westenfeld, A. Gawlik, E. de Heer, and A. Distler Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis Nephrol. Dial. Transplant., January 1, 2000; 15(1): 16 - 22. [Abstract] [Full Text] [PDF]

				R. J. Schmidt, S. Yokota, T. S. Tracy, M. I. Sorkin, and C. Baylis Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis Am J Physiol Renal Physiol, May 1, 1999; 276(5): F794 - F797. [Abstract] [Full Text] [PDF]

				D. A. De-Souza and L. J. Greene Pharmacological Nutrition After Burn Injury J. Nutr., May 1, 1998; 128(5): 797 - 803. [Abstract] [Full Text]

				I. Huk, J. Nanobashvili, C. Neumayer, A. Punz, M. Mueller, K. Afkhampour, M. Mittlboeck, U. Losert, P. Polterauer, E. Roth, et al. L-Arginine Treatment Alters the Kinetics of Nitric Oxide and Superoxide Release and Reduces Ischemia/Reperfusion Injury in Skeletal Muscle Circulation, July 15, 1997; 96(2): 667 - 675. [Abstract] [Full Text]